FDA Inspection 1049693 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on Mar 13, 2018 in Akron, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 13, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Akron, OH (United States)